Clinical trial
A Phase III, Dose Ranging, Multi-centre, Randomised, Double Blind, Placebo Controlled, Home Use, Parallel Group Clinical Trial of Topically-applied Glyceryl Trinitrate for the Treatment of Erectile Dysfunction, With an Open Label Extension
NCT03813992 is registered in ClinicalTrials.gov with Futura Medical Developments Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Dose Ranging, Multi-centre, Randomised, Double Blind, Placebo Controlled, Home Use, Parallel Group Clinical Trial of Topically-applied Glyceryl Trinitrate for the Treatment of Erectile Dysfunction, With an Open Label Extension
- Lead sponsor
- Futura Medical Developments Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 1, 2018
- Completion date
- January 17, 2020
- Enrollment
- 1,005 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.